Luma Group is an investment firm that fuels AI-powered scientific breakthroughs by investing in pioneering life sciences companies. They focus on advancing medicine, biotechnology, and human health outcomes through a hands-on, collaborative approach. Luma goes beyond just capital, combining deep scientific expertise with a long-term investment strategy and providing full lifecycle support to entrepreneurs. Their differentiated strategy involves partnering with innovators to transform cutting-edge scientific discoveries into groundbreaking therapeutics, diagnostics, and medical devices, aiming for a significant and lasting impact on human health. They also leverage an AI-powered Healthcare Innovation initiative called Luma AI Brain Initiative (LABI) for decision-making and investment diligence.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Josh FinkFounder & Managing Member
- Themasap KhanCo-Founder & Partner
- Jamie KasuboskiPartner & Head of Research
- John GomezSenior Associate
- Miguel ChuapocoAssociate
- Negin MokhtariVenture Partner & Chief Strategy Officer of LABI